Stock listing

NASDAQ:VIE Viela Bio Inc Stock

Follow Viela Bio Inc into a list and get an email when it puts out news.

Delisted NASDAQ:VIE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:VIE
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Viela Bio Inc on 6ix

Decks
1 deck · latest Jan 10, 2020

Decks

DeckKindSlidesDate
Investor Presentation (January 2020)Investor deck29 slidesJan 10, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Chris Nolet
Other companies: ArriVent BioPharma, Inc. (Director · Since at least Jan 25, 2024); Jasper Therapeutics, Inc. (Director · Since at least Sep 24, 2021); PolarityTE Inc. (Director · Apr 6, 2020 – Jan 12, 2023 · Past); Revance Therapeutics, Inc. (Director · Jul 16, 2019 – Feb 4, 2025 · Past)
Director · Oct 2, 2019 – Mar 15, 2021 · Past
Zhengbin Yao
Other companies: Alumis Inc. (Director · Since at least Jun 27, 2024); ArriVent BioPharma, Inc. (Chairman, Chief Executive Officer · Since at least Jan 25, 2024); NexImmune, Inc. (Director · Feb 11, 2021 – Jul 5, 2023 · Past); Tanox Inc (Vice President of Research · Feb 15, 2006 – Nov 20, 2006 · Past)
Chief Executive Officer, Director · Oct 2, 2019 – Mar 13, 2021 · Past
Jörn Drappa
Other companies: Alumis Inc. (Chief Medical Officer · Since at least Jun 27, 2024); Alpine Immune Sciences Inc (Director · Jul 18, 2022 – May 20, 2024 · Past); Ventyx Biosciences Inc (Chief Medical Officer · Oct 20, 2021 – Feb 4, 2022 · Past)
Chief Medical Officer · Oct 2, 2019 – Mar 13, 2021 · Past
Rachelle Jacques
Other companies: uniQure N.V. (Director · Since at least Oct 21, 2021); Corbus Pharmaceuticals Holdings, Inc. (Director · Since at least Jun 17, 2021); Akari Therapeutics PLC (Chief Executive Officer, Director · Jan 1, 2024 – Apr 26, 2024 · Past)
Director · Mar 15, 2021 – Mar 15, 2021 · Past
Tyrell J. Rivers
Other companies: ADC Therapeutics SA (Non-Executive Director · Since at least Jan 2, 2024); PhaseBio Pharmaceuticals Inc (Director · Oct 17, 2018 – Oct 17, 2018 · Past); G1 Therapeutics Inc (Director · May 16, 2017 – May 16, 2017 · Past)
Director · Oct 2, 2019 – Mar 15, 2021 · Past
Andreas Wicki
Other companies: Harmony Biosciences Holdings, Inc. (Chief Executive Officer · Since at least Aug 18, 2020); Pacira BioSciences, Inc. (Director · Feb 2, 2011 – Mar 12, 2021 · Past)
Director · Oct 2, 2019 – Mar 13, 2021 · Past
Edward Hu
Other companies: Ambrx Biopharma Inc. (Director · Jan 1, 2023 – Jan 1, 2023 · Past); Tanox Inc (Chief Operating Officer · Feb 15, 2006 – Nov 28, 2006 · Past)
Director · Oct 2, 2019 – Mar 13, 2021 · Past
James Kastenmayer
Other companies: ArriVent BioPharma, Inc. (General Counsel · Since at least Jan 25, 2024); Spyre Therapeutics, Inc. (General Counsel · Aug 23, 2022 – Feb 23, 2023 · Past)
General Counsel · Jan 6, 2020 – Mar 15, 2021 · Past
Mitchell Chan
Other companies: Regenxbio Inc. (CHIEF FINANCIAL OFFICER · Since at least Sep 16, 2024); Avalo Therapeutics, Inc. (Director · Since at least Dec 1, 2021)
Chief Financial Officer · Oct 2, 2019 – Mar 13, 2021 · Past
Pascal Soriot
Other companies: AstraZeneca PLC (Executive Director and CEO · Since at least Oct 30, 2026); Agilent Technologies, Inc. (Director · Since at least May 20, 2025)
Director · Oct 2, 2019 – Oct 2, 2019 · Past
All 14 people
PersonSeat
Aaron RenSee Remarks · Oct 2, 2019 – Nov 18, 2020 · Past
William RagatzSenior VP, Head of Commercial · Oct 2, 2019 – Mar 13, 2021 · Past
Xiaomeng TongDirector · Oct 2, 2019 – Jun 5, 2020 · Past
Yanling CaoDirector · Oct 2, 2019 – Mar 13, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Viela Bio Inc.